Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "R03D" (68)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Aminophylline (R03DA05) 5 products
WHO-DDD
DrugBank.ca
IP
Aminophyllin Amino
10 x 10 ml
PR
PR
k.A.
Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte
● 
B
FB
G
IP
Escophyllin i.v.
5 ampoule(s) à 10 ml
3.35
8.05
k.A.
Injection solution: Theophyllinum 190 mg
G. Streuli & Co. AG
B / SO
FB
G
IP
Escophyllin i.v.
10 ampoule(s) à 10 ml
PR
13.35
k.A.
Injection solution: Theophyllinum 190 mg
G. Streuli & Co. AG
B
FB
G
IP
Escophyllin i.v.
50 ampoule(s) à 10 ml
PR
44.45
k.A.
Injection solution: Theophyllinum 190 mg
G. Streuli & Co. AG
B
FB
G
IP
CI
Phyllotemp Continus 225
60 Tablet(s)
12.74
27.30
k.A.
Delayed release tablets: Theophyllinum Et Ethylendiaminum 225 mg
Mundipharma Medical
Company
B
FB
G
Montelukast (R03DC03) 36 products
WHO-DDD
DrugBank.ca
IP
CI
CM
Lukair 4 mg
28 Tablet(s)
18.46
36.40
10 %
Chewing tablets: Montelukastum 4 mg
Organon GmbH
B / SL / SO
FB
G
IP
CI
CM
Lukair 4 mg
98 Tablet(s)
64.71
86.40
10 %
Chewing tablets: Montelukastum 4 mg
Organon GmbH
B / SL / SO
FB
G
IP
CI
CM
Lukair 5 mg
28 Tablet(s)
18.39
36.30
10 %
Chewing tablets: Montelukastum 5 mg
Organon GmbH
B / SL / SO
FB
G
IP
CI
CM
Lukair 5 mg
98 Tablet(s)
64.48
86.20
10 %
Chewing tablets: Montelukastum 5 mg
Organon GmbH
B / SL / SO
FB
G
IP
CI
CM
Lukair 4 mg
28 Sachet(s)
19.87
37.85
20 %
Granulate: Montelukastum 4 mg
Organon GmbH
B / SL / SO
FB
G
IP
CI
Singulair 4 mg
28 Sachet(s)
19.96
37.95
20 %
Granulate: Montelukastum 4 mg
Organon GmbH
B / SL / SO
FB
G
IP
CI
CM
Lukair 10 mg
28 Tablet(s)
18.39
36.35
10 %
Coated tablets: Montelukastum 10 mg
Organon GmbH
B / SL / SO
FB
G
IP
CI
CM
Lukair 10 mg
98 Tablet(s)
64.48
86.20
10 %
Coated tablets: Montelukastum 10 mg
Organon GmbH
B / SL / SO
FB
G
IP
CI
Singulair
28 Tablet(s)
18.47
36.40
10 %
Coated tablets: Montelukastum 10 mg
Organon GmbH
B / SL / SO
FB
G
IP
CI
Singulair
98 Tablet(s)
64.48
86.20
10 %
Coated tablets: Montelukastum 10 mg
Organon GmbH
B / SL / SO
FB
G
IP
CI
Singulair 5 mg
28 Tablet(s)
18.47
36.40
10 %
Kautabletten für Kinder: Montelukastum 5 mg
Organon GmbH
B / SL / SO
FB
G
IP
CI
Singulair 5 mg
98 Tablet(s)
64.48
86.20
10 %
Kautabletten für Kinder: Montelukastum 5 mg
Organon GmbH
B / SL / SO
FB
G
IP
CI
Singulair 4 mg
28 Tablet(s)
18.46
36.40
10 %
Kautabletten für Kleinkinder: Montelukastum 4 mg
Organon GmbH
B / SL / SO
FB
G
IP
CI
Singulair 4 mg
98 Tablet(s)
64.44
86.15
10 %
Kautabletten für Kleinkinder: Montelukastum 4 mg
Organon GmbH
B / SL / SO
FB
G
IP
CI
Montelukast Sandoz 4 mg
28 Tablet(s)
16.79
34.70
10 %
Chewing tablets: Montelukastum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Montelukast Sandoz 4 mg
98 Tablet(s)
58.62
80.15
10 %
Chewing tablets: Montelukastum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Montelukast Sandoz 5 mg
28 Tablet(s)
16.79
34.70
10 %
Chewing tablets: Montelukastum 5 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Montelukast Sandoz 5 mg
98 Tablet(s)
58.62
80.15
10 %
Chewing tablets: Montelukastum 5 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Montelukast Spirig HC 4
28 Tablet(s)
16.80
34.70
10 %
Chewing tablets: Montelukastum 4 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Montelukast Spirig HC 4
98 Tablet(s)
58.62
80.15
10 %
Chewing tablets: Montelukastum 4 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Montelukast Spirig HC 5
28 Tablet(s)
16.80
34.70
10 %
Chewing tablets: Montelukastum 5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Montelukast Spirig HC 5
98 Tablet(s)
58.62
80.15
10 %
Chewing tablets: Montelukastum 5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Montelukast-Mepha 4 mg
28 Tablet(s)
16.79
34.70
10 %
Chewing tablets: Montelukastum 4 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Montelukast-Mepha 4 mg
98 Tablet(s)
58.62
80.15
10 %
Chewing tablets: Montelukastum 4 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Montelukast-Mepha 5 mg
28 Tablet(s)
16.79
34.70
10 %
Chewing tablets: Montelukastum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Montelukast-Mepha 5 mg
98 Tablet(s)
58.62
80.15
10 %
Chewing tablets: Montelukastum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Montelukast Sandoz 4
28 Sachet(s)
16.79
34.70
10 %
Granulate: Montelukastum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Montelukast-Mepha 4
28 piece(s)
16.79
34.70
10 %
Granulate: Montelukastum 4 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Montelukast Sandoz 10 mg
28 Tablet(s)
16.79
34.70
10 %
Coated tablets: Montelukastum 10 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Montelukast Sandoz 10 mg
98 Tablet(s)
58.62
80.20
10 %
Coated tablets: Montelukastum 10 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Montelukast Spirig HC 10
30
18.00
35.95
10 %
Coated tablets: Montelukastum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Montelukast Spirig HC 10
100
59.82
81.40
10 %
Coated tablets: Montelukastum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Montelukast Zentiva 10 mg
28
16.70
34.60
10 %
Coated tablets: Montelukastum 10 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Montelukast Zentiva 10 mg
98
58.62
80.20
10 %
Coated tablets: Montelukastum 10 mg
Helvepharm AG
B / SL / SG
FB
G
IP
Montelukast-Mepha 10 mg
28 Tablet(s)
16.79
34.70
10 %
Coated tablets: Montelukastum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Montelukast-Mepha 10 mg
98 Tablet(s)
58.62
80.20
10 %
Coated tablets: Montelukastum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
Omalizumab (R03DX05) 12 products
WHO-DDD
DrugBank.ca
L
IP
CI
Xolair 75 mg/0.5 ml
187.92
220.80
10 %
Injection solution in prefilled syringe: Omalizumabum 75mg / 0.5ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Xolair 150 mg/1.0 ml
375.83
425.15
10 %
Injection solution in prefilled syringe: Omalizumabum 150mg / 1ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
Xolair 300 mg/2 ml
751.66
833.90
10 %
Injection solution in prefilled syringe: Omalizumabum 300mg / 2ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
Xolair 150 mg/1.0 ml
375.83
425.15
10 %
Injektionslösung in einem Fertigpen: Omalizumabum 150 mg/ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
Xolair 300 mg/2.0 ml
751.66
833.90
10 %
Injektionslösung in einem Fertigpen: Omalizumabum 300mg / 2ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Xolair 75 mg/0.5 ml
PR
PR
k.A.
Injektionslösung in einem Fertigpen: Omalizumabum 75mg / 0.5ml
Novartis Pharma
Schweiz AG
B
FB
G
Omlyclo 75 mg/0.5 ml
PR
PR
k.A.
solution injectable en seringue préremplie: Omalizumabum 75mg / 0.5ml
iQone Healthcare
Switzerland SA
B
FB
G
Omlyclo 150 mg/1 ml
PR
PR
k.A.
solution injectable en seringue préremplie: Omalizumabum 150 mg/ml
iQone Healthcare
Switzerland SA
B
FB
G
L
IP
CI
Xolair 75 mg/0.5 ml
187.92
220.80
10 %
Injection solution in prefilled syringe: Omalizumabum 75mg / 0.5ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Xolair 150 mg/1.0 ml
375.83
425.15
10 %
Injection solution in prefilled syringe: Omalizumabum 150mg / 1ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
SIP
IP
CI
Xolair 150 mg
ampoule(s)
375.83
425.15
10 %
Lyophilisate and solvent: Omalizumabum 150 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
SIP
IP
CI
Xolair 75 mg
ampoule(s)
PR
PR
k.A.
Lyophilisate and solvent: Omalizumabum 75 mg
Novartis Pharma
Schweiz AG
B
FB
G
Roflumilast (R03DX07) 2 products
WHO-DDD
DrugBank.ca
IP
CI
Daxas 500 ug
30 Tablet(s)
54.06
75.20
10 %
Coated tablets: Roflumilastum 500 µg
AstraZeneca AG
B / SL
FB
G
IP
CI
Daxas 500 ug
90 Tablet(s)
137.85
166.35
10 %
Coated tablets: Roflumilastum 500 µg
AstraZeneca AG
B / SL
FB
G
Reslizumab (R03DX08) 2 products
WHO-DDD
L
IP
Cinqaero 100 mg/10 mL
567.21
633.30
10 %
Concentrate for infusion: Reslizumabum 100mg / 10ml
Teva Pharma AG
B / SL
FB
G
L
IP
Cinqaero 25 mg/2,5 mL
141.81
170.65
10 %
Concentrate for infusion: Reslizumabum 25mg / 2.5ml
Teva Pharma AG
B / SL
FB
G
Mepolizumab (R03DX09) 5 products
WHO-DDD
L
IP
Nucala 100 mg
976.63
1078.55
10 %
Lyophilisate: Mepolizumabum 100 mg
GlaxoSmithKline AG
● 
B / SL
FB
G
L
IP
CI
Nucala 100 mg/mL
976.63
1078.55
10 %
Injektionslösung im Fertigpen: Mepolizumabum 100mg / 1ml
GlaxoSmithKline AG
B / SL
FB
G
L
IP
CI
Nucala 100 mg/mL
3 x 1
2929.89
3202.85
10 %
Injektionslösung im Fertigpen: Mepolizumabum 100mg / 1ml
GlaxoSmithKline AG
B / SL
FB
G
L
IP
Nucala 100 mg/mL
976.63
1078.55
10 %
Injektionslösung in der Fertigspritze: Mepolizumabum 100mg / 1ml
GlaxoSmithKline AG
B / SL
FB
G
IP
Nucala 100 mg/mL
3 x 1
PR
PR
k.A.
Injektionslösung in der Fertigspritze: Mepolizumabum 100mg / 1ml
GlaxoSmithKline AG
B
FB
G
Benralizumab (R03DX10) 2 products
WHO-DDD
L
IP
CI
Fasenra 30 mg /1 ml
2319.39
2538.90
10 %
Injection solution in prefilled syringe: Benralizumabum 30 mg/ml
AstraZeneca AG
B / SL
FB
G
L
IP
CI
Fasenra Pen 30 mg /1 ml
2319.39
2538.90
10 %
lnjektionslösung: Benralizumabum 30 mg/ml
AstraZeneca AG
B / SL
FB
G
Tezepelumab (R03DX11) 2 products
WHO-DDD
L
IP
CI
Tezspire 110 mg/ml
1036.42
1143.60
10 %
Injektionslösung in einem Fertigpen: Tezepelumabum 210 mg
AstraZeneca AG
B / SL
FB
G
L
IP
CI
Tezspire
1036.42
1143.60
10 %
Injection solution in prefilled syringe: Tezepelumabum 210 mg
AstraZeneca AG
B / SL
FB
G
(R03DZ) 2 products
WHO-DDD
CI
H
Regenaplex Nr. 24c
15 ml
PR
PR
k.A.
Tropfen zum Einnehmen: 10 Active Agents
Regena AG
D
FB
G
CI
H
Regenaplex Nr. 24b
15 ml
PR
PR
k.A.
Tropfen zum Einnehmen: 10 Active Agents
Regena AG
D
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home